Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

LifeStance Health (LFST) Other Operating Expenses (2020 - 2025)

LifeStance Health (LFST) has disclosed Other Operating Expenses for 6 consecutive years, with $269.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Other Operating Expenses rose 16.74% to $269.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.0 billion, a 10.7% increase, with the full-year FY2025 number at $1.0 billion, up 10.7% from a year prior.
  • Other Operating Expenses was $269.3 million for Q4 2025 at LifeStance Health, up from $260.8 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $269.3 million in Q4 2025 to a low of $111.4 million in Q1 2021.
  • A 5-year average of $199.2 million and a median of $206.2 million in 2023 define the central range for Other Operating Expenses.
  • Peak YoY movement for Other Operating Expenses: surged 232.67% in 2021, then rose 3.79% in 2025.
  • LifeStance Health's Other Operating Expenses stood at $151.1 million in 2021, then increased by 22.8% to $185.6 million in 2022, then increased by 18.3% to $219.5 million in 2023, then rose by 5.11% to $230.7 million in 2024, then increased by 16.74% to $269.3 million in 2025.
  • Per Business Quant, the three most recent readings for LFST's Other Operating Expenses are $269.3 million (Q4 2025), $260.8 million (Q3 2025), and $250.9 million (Q2 2025).